GSK Investigational Site

Cowansville, Quebec J2K 2X9

0 studies enrolling now · 1 studies all time

What they study most

Pulmonary Disease, Chronic Obstructive

Studies at this site

• ADVAIR® DISKUS® Inhaler (Fluticasone Propionate/Salmeterol) Versus SEREVENT® DISKUS® Inhaler (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations. ADVAIR® DISKUS® Inhaler and SEREVENT® DISKUS® Inhaler Are Trademarks of the GSK Group of Companies. — Completed